Methyprylon
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | noludar | — | — | |
| Safety | ||||
| Dose · Oral | ||||
| Light | 150–200 mg | — | — | |
| Common | 200–300 mg | — | — | |
| Duration | ||||
| Total | 6–12 hours | — | — | |
| After-effects | 1–16 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | — | GABRA1 | |
| Half-life | — | 6-16 hours PLASMA T1/2 IS 4 HR, BUT IT IS LONGER IN ACUTE INTOXICATION. Plasma half-life is 6 to 16 hours. Onset of action within 45 minutes. Duration of action 5 to 8 hours. Biologic half-life is not well defined, but varies between 4 and 16 hours, although a longer action has been observed in severely poisoned patients. | — | |
| Protein binding | — | 60% | — | |
TripSit summary
Sedative of the pipeidinedone family. Was used for treating insomnia, yet is rarely used today due to substances with fewer side effects, such as benzodiazepines.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.